Modification of PAR-10-186: NIAID Clinical Trial Implementation Cooperative Agreement (U01)


Notice Number:  NOT-AI-11-025

Key Dates

Release Date:  January 6, 2011

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to announce a substantive change to requirements articulated in PAR-10-186: NIAID Clinical Trial Implementation Cooperative Agreement (U01) and to provide a clarification for PAR-10-186: NIAID Clinical Trial Implementation Cooperative Agreement (U01).  

In Part II-Full Text of Announcement, Section I. Funding Opportunity Description, 1. Research Objectives, under "Scope, paragraph 6, line 3”:

Delete "include a randomized design" from the sentence that reads: "The trial must be hypothesis- driven, include a randomized design, and have clear primary and secondary endpoints."

Randomization is only required for those trials for which it is an appropriate element of trial design.

In Section IV. Application and Submission Information, 6. "Other Submission Requirements" section:

Add the following instructions:

The order of assembly of the application should be as follows:

Specific Aims                                                   1 page

Research Strategy                                          12 pages

HS Section                                                       no page limit, place after Research Plan

Clinical Protocol Synopsis                           3 pages, place after HS section

Data and Safety Monitoring Plan                 no page limit, place after Clinical Protocol Synopsis

Milestone Plan                                                3 pages, place after Data and Safety Monitoring Plan Complete Clinical Protocol no page limit, place after DSMP

All other aspects of  PAR-10-186 remain unchanged.

Inquiries

Please direct all inquiries to:

Anna Ramsey-Ewing, Ph.D.
Associate Director for Extramural Science Policy
Office of the Director
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
6700-B Rockledge Drive, MSC 7610
Bethesda, MD 20892-7610
Phone: (301) 435-8536
FAX: (301) 402-0369
E-mail:  ar15o@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.